Bio-Rad Laboratories, Inc (BIO) Stock Price

381.57 ▲ +12.57 (+3.41%)
Open: 364.45 Vol: 273.2K Day's range: 363.59 - 384.62 Nov 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 382.69▼ 382.13▼ 383.23▼ 374.33▲ 368.71▲
MA10 382.43▼ 382.61▼ 378.24▲ 376.68▲ 372.55▲
MA20 382.08▼ 377.53▲ 377.08▲ 368.86▲ 352.00▲
MA50 382.68▼ 376.14▲ 376.19▲ 373.62▲ 313.34▲
MA100 378.55▲ 376.63▲ 371.73▲ 348.70▲ 297.20▲
MA200 376.69▲ 370.36▲ 368.80▲ 314.94▲ 326.52▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.046▲ 0.382▲ 1.053▲ 1.064▲ -0.458▼
RSI 47.829▼ 57.137▲ 58.331▲ 56.115▲ 63.940▲
STOCH 64.673     70.867     93.264▲ 59.425     47.858    
WILL %R -59.401     -13.510▲ -12.360▲ -20.028▲ -19.103▲
CCI -4.595     43.678     79.524     47.896     17.322    
Latest Filters Detected On BIO
RSI $BIO RSI(14) Crossed Above 50 Set Alert
MA $BIO Price Crossed Above MA(50) Set Alert
MA $BIO Price Crossed Above MA(13) Set Alert
MA $BIO Price Crossed Above MA(7) Set Alert
Bio-Rad Laboratories, Inc News
Is Bio-Rad Laboratories, Inc. (BIO) an Activist Investor Target With Significant Hidden Value
Saturday, November 07, 2026 04:22 AM
We have just published our list of the 10 Activist Target Stocks with High Cash and Low Valuations, with Bio-Rad Laboratories ranked 8th on the list. Bio-Rad Laboratories, Inc. (NYSE:BIO) is an ...
Bio-Rad expands precision oncology research portfolio for advanced molecular analysis workflows
Thursday, November 05, 2026 04:00 PM
Expanded portfolio Includes new droplet digital PCR assays, Reagents and technologies to support oncology research applications and extend the capabilities of the QX700 ddPCR systems ...
BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Prices $21 Million Public Offering to Support Buntanetap Clinical Development
Thursday, November 05, 2026 09:26 AM
Canaccord Genuity is acting as sole bookrunner. Annovis intends to use the net proceeds to support continued clinical development of its investigational oral therapy buntanetap for Alzheimer’s disease ...
BIO historical stock data
date open high low close volume
06/11/26 364.45 384.62 363.59 381.57 273,200
05/11/26 367.29 375.07 352.09 369.00 433,887
04/11/26 380.05 382.00 371.54 379.99 281,795
03/11/26 369.45 376.81 369.45 374.91 214,402
02/11/26 374.79 377.90 361.265 366.16 209,398
30/10/26 381.09 384.00 368.445 372.18 183,084
29/10/26 389.15 390.155 379.235 384.40 332,334
28/10/26 384.15 388.86 379.79 385.12 251,297
27/10/26 376.25 381.87 369.33 380.99 167,131
26/10/26 371.80 376.00 369.755 372.43 177,818
Quote Details
52wk Low:236.73
52wk High:396.23
Vol:273.2K
Avg Vol(3m):4M
1Y Chng:+18.32%
1M Chng:+1.03%
Add to Watch List
More Information
Index N/A
Market Cap. 9.87B